AA | Tuesday, April 20, 2021 – 17:09 | Last Updated: 20 04 2021 – 17:10
Under the leadership of the Ministry of Health and the Ministry of Industry and Technology and with the mobilization of Arçelik, ASELSAN, Baykar and Biosys engineers, the Biovent Intensive Care Type Mechanical Ventilator Device, which started mass production last year, is used in more than 30 countries.
Speaking to Anadolu Agency (AA), Biosys Biomedical Founder and General Manager Cemal Erdoğan said that they established Biosys in 2012 with the support of the Ministry of Industry and Technology and that they are trying to develop the best by designing 3 different respirators in 5 years.
actively used in Turkey’s 81 provinces
Stating that the software of the domestic breathing apparatus has been improved and important developments have been made in Baykar, Erdoğan said:
“Later, preparations were made for mass production in Arçelik and we started production in 2 weeks. During this period, we worked with Baykar, ASELSAN and Arçelik engineers for 18-20 hours a day. The first 5 thousand devices were produced and distributed in Arçelik. passed ASELSAN. currently also it continues in production ASELSAN. production up to day 300 at the maximum capacity can be made. so far produced about 20 thousand pieces of equipment, and is currently actively being used and Turkey’s 81 provinces many countries.
During the epidemic, respirators became very valuable and almost unavailable. There was also not enough production. There are a limited number of companies producing in the world. The whole world was caught off guard. If the domestic production of this device was not provided, it would be very difficult to reach the required device. Countries wanted their companies to meet the needs of their own countries first, and some restrictions were imposed. Thanks to locally produced Biyovent, we both met more than the need in our own country and sent our devices to more than 30 countries. “
Half of manufactured respirators were exported abroad
Erdogan stated that the domestic respiratory device has more than enough features compared to its counterparts and that the “High Flow Oxygen Therapy” feature in it is very useful in the treatment of Kovid-19, continued his words as follows:
“We receive very positive comments from our healthcare professionals. In addition, we quickly complete the improvements and make updates in the field on the parts they want us to improve. We are currently working on a device used in the treatment of Kovid-19 and we will make an announcement within a few weeks. We work hard to make the most advanced version of the respiratory device. At the same time, we are conducting the R&D process of 8 different medical devices that are not locally produced. We aim to end foreign dependency in some very important items in medical device technologies. “